1 / 4

Wearable Cardioverter Defibrillators Market

Analysis of Wearable Cardioverter Defibrillators Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~6% During 2024-2036 and Attain ~USD 24 Billion by 2036

Utkarsha3
Download Presentation

Wearable Cardioverter Defibrillators Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Analysis of Wearable Cardioverter Defibrillators Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~6% During 2024-2036 and Attain ~USD 24 Billion by 2036 Research Nester assesses the growth and market size of global wearable cardioverter defibrillators market which is anticipated to be on account of the growing cardiovascular disorders across the globe and growing senior population New York – October 30, 2023- Research Nester’s recent market research analysis on “Wearable Cardioverter Defibrillators Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global Wearable Cardioverter Defibrillators market in terms of market segmentation by indication, end-use, demography, and by region. Growing Consumption of Tobacco to Promote Global Market Share of Wearable Cardioverter Defibrillators The global wearable cardioverter defibrillators market is estimated to grow majorly on account of the increasing intake of tobacco. Smokers have an increased risk of heart attacks, hypertension, blood clots, strokes, hemorrhages, aneurysms, and other cardiovascular diseases such as peripheral artery disease which is a buildup of plaque, which consists of lipids and cholesterol, in the arteries of the arms or legs. This may result in increasing demand for wearable cardioverter defibrillators which is a non-invasive technology for the treatment of sudden cardiac death (SCD). Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-874 Some of the major growth factors and challenges that are associated with the growth of the global wearable cardioverter defibrillators market are:

  2. Growth Drivers: Surge in Trend of Minimally Invasive Procedures Rising Cases of Diabetes Challenges: The lack of awareness about the benefits of Wearable Cardioverter Defibrillators, and the stringent regulations developed by the government of nations worldwide are some of the major factors anticipated to hamper the global market size of wearable cardioverter defibrillators. The lack of awareness regarding cardioverter-defibrillators in emerging nations owing to the lack of sufficient resources to provide knowledge about these devices to the people. By indication, the global wearable cardioverter defibrillators market is segmented into myocardial infarction, congenital heart disease, ventricular arrhythmias, peripartum cardiomyopathy, tetralogy Of fallot, and wolff-parkinson-white syndrome. The peripartum cardiomyopathy segment is to garner a highest revenue by the end of 2036 by growing at a significant CAGR over the forecast period. Pregnancy-associated cardiomyopathy is a kind of systolic heart failure (HF) that affects women during pregnancy or in the months after giving birth which is characterized by a decreased left ventricular ejection fraction (LVEF). This is anticipated to increase demand for wearable cardioverter defibrillators as they are beneficial for conditions like peripartum cardiomyopathy. Additionally, the ventricular arrhythmiassegment is to garner a highest revenue by the end of 2036. Ventricular arrhythmias are irregular cardiac rhythms that start in the lower heart chambers can be extremely hazardous and usually need immediate medical attention. Moreover, it has been demonstrated that the wearable cardioverter defibrillator can

  3. identify ventricular fibrillation (VF) and ventricular tachycardia (VT), and increase survival rates following abrupt cardiac arrest. Request for customization @ https://www.researchnester.com/customized-reports-874 By region, the Europe wearable cardioverter defibrillators market is to generate the highest revenue by the end of 2036. This growth is anticipated by increasing elderly population in the region. This has led to a rise in the prevalence of diabetes in the region which is acknowledged as a significant contributor to early mortality and disability. Additionally, high blood pressure and high cholesterol are risk factors that raise the likelihood of heart attacks and strokes in people with diabetes as elevated blood sugar levels have the potential to harm blood vessels and heart- controlling neurons. All these factors may create a huge demand for wearable cardioverter defibrillators in the region. For instance, Italy had the highest proportion of elderly people in all of Europe with over 22% of the overall population 65 years of age and older in 2022. Besides this, every adult in Europe who is at least 15 years old drinks more than 9 liters of pure alcohol annually. For instance, Latvia had the highest alcohol consumption rate in Europe in 2021, at over 12 liters per person. Moreover, research has demonstrated that consuming alcohol, even in small doses, can raise one's risk of heart disease such as heart failure, or stroke, as elevated blood pressure can result from excessive alcohol use. Furthermore, drinking alcohol affects the heart and can lead to hypertension and cardiomyopathy, which damages the heart muscle, which is one of the main causes of cardiac arrest. All these factors are expected to drive the demand for wearable cardioverter defibrillators in the region.

  4. This report also provides the existing competitive scenario of some of the key players of the global wearable cardioverter defibrillators market which includes company profiling of ZOLL Medical Corporation, Element Science Inc., Medtronic plc, Kestra Medical Technologies, Inc., Abbott, Boston Scientific Corporation, LivaNova plc, Koninklijke Philips N.V., Nihon Kohden Corporation and General Electric Company., and others., and others. Access our detailed report @ https://www.researchnester.com/reports/wearable- cardioverter-defibrillator-market/874 Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties. Contact for more Info: AJ Daniel Email: info@researchnester.com U.S. Phone: +1 646 586 9123 U.K. Phone: +44 203 608 5919

More Related